Twenty months after the launch of the Make in India campaign, the government has begun assessing the impact of PM Narendra Modi´s flagship programme and is looking to even tweak some of the elements.
FlashNews:
InfraPandit Awards to Honour Doctoral Excellence in Infrastructure
REC Wins Leading CSR and Sustainability Award for Healthcare Support
HAL Set to Enter New Global Space Race with SSLV Contract Win
Multimodal Logistics: Optimising Assets, Strengthening Supply Chains
Gadkari Announces FASTag Annual Pass to Ease Private Vehicle Movement from Independence Day
Air India 171 Crash: A Definitive Inflection Point for Indian Aviation
REC Reports Strong Profit Growth
GAIL Reports Record Profit Surge
India Calls for Inclusive Energy Governance at BRICS Meet
Mumbai-Ahmedabad Bullet Train’s 300 km Viaduct Milestone
India Revokes Security Clearance to Turkish Firm Çelebi
Major Ports Handle Record Cargo Throughput in FY2025
India Committed to Unlocking Energy Potential: Puri
Gaganyaan Scheduled for 2027 Launch
Defence Budget Set for Rs.500 Billion Top-up
Operation Sindoor: The Indigenous Edge
Securing India’s New Crown Jewels
Logistics parks, multimodal cargo hubs poised for rapid growth
India is ready to build for the world!
Home » Pharma
Tag: Pharma
Manufacturing awaits Infrastructure
It is against a challenging backdrop that the ´Make in India´ campaign promises much. To be sure, the country´s manufacturing sector is at a critical point. And it´s been stuck there for sometime now.